Rhythm is a biopharmaceutical company that develops and commercializes peptide therapeutics for the treatment of genetic disorders.
Business Model:
Revenue: $16.7M
Employees: 51-200
Address: 222 Berkeley Street
City: Boston
State: MA
Zip: 02116
Country: US
Rhythm is a biopharmaceutical company that develops and commercializes peptide therapeutics for the treatment of genetic disorders.
Contact Phone:
+18572644280
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
10/5/2017
IPO Valuation:
$443M
Ticker Symbol:
RYTM
IPO Price:
$17/share
Amount Raised:
$120M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|---|---|
2/2023 | Xinvento |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|